The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)

CompletedOBSERVATIONAL
Enrollment

2,039

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Need for MRI Imaging With Pacemaker orImplantable Cardioverter Defibrillator Implanted
Interventions
DEVICE

MRI with pacemaker or ICD

The aim of the present protocol is to prospectively determine the adverse event rate of non-thoracic MRI for patients with implanted cardiac devices by collecting pre- and post-MRI device interrogations in a multi-center registry.

Trial Locations (21)

10128

Advanced Cardiovascular Imaging, New York

15212

Allegheny General Hospital, Pittsburgh

19001

Abington Health System, Abington

33180

Aventura Hospital and Medical Center, Aventura

39216

University of Mississippi Medical Center, Jackson

40503

Baptist Health Lexington, Lexington

46804

Northern Indiana Research Alliance, Fort Wayne

48075

Providence Heart Institute, Southfield

53215

Aurora St. Luke's Medical Center, Milwaukee

53226

Medical College of Wisconsin, Milwaukee

74133

Oklahoma Heart Research and Education Foundation, Tulsa

77030

The Methodist Hospital, Houston

84157

Intermountain Medical Center, Murray

90095

UCLA Cardiac Arrhythmia Center, Los Angeles

91505

Providence St. Joseph Medical Center, Burbank

92037

Scripps Clinic/Green Hospital, La Jolla

Scripps Memorial Hospital, La Jolla

92103

University of California, San Diego, San Diego

92553

Spectrum Clinical Research, Moreno Valley

06520

Yale University School of Medicine, New Haven

07450

The Valley Hospital, Ridgewood

All Listed Sponsors
collaborator

Scripps Clinic

OTHER

collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Biotronik, Inc.

INDUSTRY

lead

Scripps Health

OTHER